Home » Topics » BioWorld Science

BioWorld Science
RSS

Generon presents phase II data for F-652 in acute GVHD

Feb. 27, 2020

Proof-of-concept data for novel anti-CD300f ADC in preclinical models of AML

Feb. 27, 2020

Prospective comparison of [68Ga]RM-2 and [68Ga]PSMA-617 PET/CT in prostate cancer

Feb. 27, 2020

Novavax produces nanoparticle COVID-19 vaccine candidates

Feb. 27, 2020

Pilot study of APN-01 for the treatment of coronavirus disease COVID-19 in China

Feb. 27, 2020

New MRI contrast agent specifically targeting CXCR4 in liver metastases may allow early detection

Feb. 27, 2020

S100A12 is upregulated in papillary thyroid cancer and may serve as a diagnostic biomarker

Feb. 27, 2020

Autophagy activation may prevent metastasis

Feb. 27, 2020

Structural insights could enable specific activation of GPCRs

Feb. 27, 2020

ProMIS announces pilot longitudinal study to assess blood-based biomarkers for Alzheimer's

Feb. 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...